Cargando…
The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
BACKGROUND: Schistosomiasis remains an endemic parasitic disease causing much morbidity and, in some cases, mortality. The World Health Organization (WHO) has outlined strategies and goals to combat the burden of disease caused by schistosomiasis. The first goal is morbidity control, which is define...
Autores principales: | Kura, Klodeta, Hardwick, Robert J., Truscott, James E., Toor, Jaspreet, Hollingsworth, T. Deirdre, Anderson, Roy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672840/ https://www.ncbi.nlm.nih.gov/pubmed/33203467 http://dx.doi.org/10.1186/s13071-020-04409-3 |
Ejemplares similares
-
Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
por: Kura, Klodeta, et al.
Publicado: (2019) -
Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
por: Kura, Klodeta, et al.
Publicado: (2022) -
Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
por: Toor, Jaspreet, et al.
Publicado: (2020) -
Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration
por: Kura, Klodeta, et al.
Publicado: (2020) -
Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment
por: Ayabina, Diepreye, et al.
Publicado: (2021)